Acute Porphyria Drug Database

Monograph

N07BB03 - Acamprosate
Propably not porphyrinogenic
PNP

Rationale
Structurally related to taurine and GABA. Not metabolised, excreted in unchanged form in urine. One reference consider it safe.
Chemical description
Aliphatic aminopropane sulfonate. Used to reduce risk for relapse in alcohol dependence. Structurally related taurine and GABA. Its acetylation permits passage through the blood-brain barrier. Excreted in unchanged form by the kidneys. French list: use

Similar drugs
Explore alternative drugs in similar therapeutic classes N07B / N07BB or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Campral · Campral 333 mg, maagsapresistente tabletten · Campral, maagsapresistente tabletten 333 mg
Belgium
Campral · Campral 333 mg compr. gastro-résist.
United Kingdom
Acamprosate · Acamprosate 333mg gastro-resistant tablets · Campral EC · Campral EC 333mg tablets
Denmark
Acamprosatcalcium · Acamprosatcalcium "2care4" · Campral
Norway
Campral
Poland
Campral
Luxembourg
CAMPRAL
Serbia
Campral · Campral®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙